Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_provenance.
- NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_assertion description "[Taking advantage of our recently identified novel selective antagonist for the EP2 (PTGER2) subtype of PGE(2) receptor, we demonstrated that EP2 receptor activation could promote prostate cancer cell growth and invasion in vitro, accompanied by upregulation of the tumor-promoting inflammatory cytokines, such as IL-1? and IL-6.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_provenance.
- NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_assertion evidence source_evidence_literature NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_provenance.
- NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_assertion SIO_000772 23192657 NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_provenance.
- NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_assertion wasDerivedFrom befree-20150227 NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_provenance.
- NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_assertion wasGeneratedBy ECO_0000203 NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_provenance.
- befree-20150227 importedOn "2015-02-27" NP655576.RAk-boqo0qwar6pRbvptKa-DqqL7a2-GlWRpcb6Www6-I130_provenance.